Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Monlunabant

A Research Study Investigating Safety and Concentration in the Blood After One Dose Tablet of the New Medicine Monlunabant in Healthy Weight Japanese and Caucasian Men

Inversago Pharma · Phase 1 · Completed · Enrollment 73

NCT06542536

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Monlunabant dose 1n/rn/rn/rn/r
Monlunabant dose 2n/rn/rn/rn/r
Monlunabant dose 3n/rn/rn/rn/r
Placebo (monlunabant)n/rn/rn/rn/r

Not shown

  • Monlunabant dose 1: endpoint not reported
  • Monlunabant dose 2: endpoint not reported
  • Monlunabant dose 3: endpoint not reported
  • Placebo (monlunabant): endpoint not reported